Showing 1 - 11 results of 11 for search '"Therapeutic Advances in Neurological Disorders"', query time: 0.04s Refine Results
  1. 1
    A multi-country cohort database study to assess pregnancy and infant outcomes after potential maternal or paternal exposure to cladribine tablets in the treatment of multiple sclerosis: the CLEAR study methods and status update

    A multi-country cohort database study to assess pregnancy and infant outcomes after potential maternal or paternal exposure to cladribine tablets in the treatment of multiple scler... by Kerstin Hellwig, Melinda Magyari, Thomas M. MacDonald, Carolyn E. Cesta, Stig Wergeland, Maarit K. Leinonen, Asher Ornoy, Sandra Vukusic, Alexandra Lauer, Xiaolei Zhou, Alison Kawai, Rachel Weinrib, Alejandro Arana, Tahani Boumenna

    Published 2025-01-01
    “…Therapeutic Advances in Neurological Disorders…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Predictors and lesion patterns of dysphagia and swallowing outcomes after acute intracerebral hemorrhage

    Predictors and lesion patterns of dysphagia and swallowing outcomes after acute intracerebral hemorrhage by Xiao Hu, Min Wang, Zijie Wang, Yanfang Xie, Mengqiu Zhang, Shanyu Zhang, Tiannan Yang, Chuanqin Fang, Libo Zhao, Yanghua Tian, Qi Li

    Published 2025-01-01
    “…Therapeutic Advances in Neurological Disorders…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Tofersen and other antisense oligonucleotides in ALS

    Tofersen and other antisense oligonucleotides in ALS by Albert Ludolph, Maximilian Wiesenfarth

    Published 2025-01-01
    “…Therapeutic Advances in Neurological Disorders…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world study

    Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world study by Tjalf Ziemssen, Ann D. Bass, Bart Van Wijmeersch, Sara Eichau, Stephan Richter, Frank Hoffmann, Nicole M. Armstrong, Magdalena Chirieac, Janete Cunha-Santos, Barry A. Singer

    Published 2025-02-01
    “…Therapeutic Advances in Neurological Disorders…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Oral supplementation with propionate is reflected in the serum of healthy individuals

    Oral supplementation with propionate is reflected in the serum of healthy individuals by Maximilian Schröder, Arijan Pasic, Frank Hirche, Svitlana Rozanova, Melissa Sgodzai, Barbara Gisevius, Lea Horstkemper, Ralf Gold, Katrin Marcus, Kalliopi Pitarokoili, Jeremias Motte, Katalin Barkovits, Gabriele Stangl, Anna Lena Fisse

    Published 2025-01-01
    “…Therapeutic Advances in Neurological Disorders…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Vaccination coverage and its determinants in patients with multiple sclerosis—a multicenter cross-sectional study

    Vaccination coverage and its determinants in patients with multiple sclerosis—a multicenter cross-sectional study by Paula Schade, Hai-Anh Nguyen, Julia Steinle, Kerstin Hellwig, Teodor Pelea, Philipp Franken, Birte Elias-Hamp, Veit Becker, Stefan Merkelbach, Stephan Richter, Bert Wagner, Christian Geis, Matthias Schwab, Florian Rakers

    Published 2025-01-01
    “…Therapeutic Advances in Neurological Disorders…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Erratum to “Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance”

    Erratum to “Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance”

    Published 2025-01-01
    “…Therapeutic Advances in Neurological Disorders…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Drug-induced dementia: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database

    Drug-induced dementia: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database by Lisi Xu, Ruonan Zhang, Xiaolin Zhang, Xiuli Shang, Daifa Huang

    Published 2025-01-01
    “…Therapeutic Advances in Neurological Disorders…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Evaluating neurofilament light chain serum levels as a diagnostic marker for Lyme neuroborreliosis

    Evaluating neurofilament light chain serum levels as a diagnostic marker for Lyme neuroborreliosis by Cédric Hirzel, Annina Grütter, Denis Grandgirard, Robert Hoepner, Franziska Suter-Riniker, Stephen L. Leib

    Published 2025-01-01
    “…Therapeutic Advances in Neurological Disorders…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance

    Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance by Assunta Dal-Bianco, Jiwon Oh, Pascal Sati, Martina Absinta

    Published 2024-12-01
    “…Therapeutic Advances in Neurological Disorders…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Application of efgartigimod in Chinese patients with myasthenia gravis: a single-center real-world prospective study

    Application of efgartigimod in Chinese patients with myasthenia gravis: a single-center real-world prospective study by Geke Zhu, Han Zhou, Wanying Wang, Yongbo Ma, Xiangtao Nie, Wenjing Qi, Lei Hao, Xiuming Guo

    Published 2025-01-01
    “…Therapeutic Advances in Neurological Disorders…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: